Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

GSK Announces China National Medical Products Administration Acceptance for Nucala (mepolizumab)

Wednesday, March 15, 2023

GSK announced that the China National Medical Products Administration has accepted for review a new drug application for Nucala mepolizumab as an addon maintenance treatment for severe eosinophilic asthma SEA If approved Nucala would be the first tar...

AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals

Wednesday, March 15, 2023

AcelRx Pharmaceuticals announced the divestment of its FDAapproved drug DSUVIA to Alora Pharmaceuticals Alora The agreement allows AcelRx to participate in the longterm value expected to be created by Alora as they expand the commercialisation of DS...

Pfizer and BioNTech Receive U.S. Emergency Use Authorisation of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster

Wednesday, March 15, 2023

Pfizer and BioNTech announced that the US Food and Drug Administration FDA granted emergency use authorisation EUA to provide a single booster dose of the companies Omicron BABAadapted bivalent COVID vaccine in children months through years of age...

Pfizer Acquires Seagen with an Investment of US$43 Billion

Tuesday, March 14, 2023

Pfizer and Seagen announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen for US in cash per Seagen share for a total enterprise value of US billion Together Pfizer and Seagen will accelerate the nex...

Sanofi Acquires Provention Bio

Tuesday, March 14, 2023

Sanofi and Provention Bio entered into an agreement under which Sanofi has agreed to acquire Provention Bio for per share in cash representing an equity value of approximately billion The acquisition of Provention Bio builds on Sanofis mission deli...

ALX Oncology and Quantum Leap Healthcare Collaborative™ Announce First Patient Dosed in the I-SPY-P1 TRIAL

Monday, March 13, 2023

ALX Oncology Holdings and Quantum Leap Healthcare Collaborative Quantum Leap announced that the first patient has been dosed in the ISPYPTRIAL for the treatment of patients with unresectable or metastatic HERpositive and HERlow breast cancer This Pha...

Cingulate and Indegene Announce Joint Commercialisation Agreement

Monday, March 13, 2023

Cingulate and Indegene announced a joint commercialisation agreement to provide commercial support for Cingulates lead candidate CTx dexmethylphenidate a novel investigational treatment being developed as a true oncedaily stimulant medication for att...

Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Collaboration

Friday, March 10, 2023

Alnylam Pharmaceuticals and Medison Pharma Medison announced an expansion of the existing partnership to a multiregional agreement that includes Poland Czech Republic Hungary Slovakia Lithuania Estonia and Latvia in addition to Israel This new agreem...

Vertex Announces FDA Clearance of Investigational New Drug Application for VX-264

Friday, March 10, 2023

Vertex Pharmaceuticals Incorporated announced that the US Food and Drug Administration FDA has cleared the Investigational New Drug Application IND for VX a stem cellderived fully differentiated pancreatic islet cell therapy encapsulated into a Verte...

Kiora Pharmaceuticals Receives Investigational New Drug Approval for Phase 2 Study of KIO-101

Wednesday, March 08, 2023

Kiora Pharmaceuticals announced it has received investigational new drug application approval for a Phase study of KIO for the treatment of the Ocular Presentation of Rheumatoid Arthritis and other autoimmune diseases OPRA This study will enrol appr...